You are here

  • Home
  • Archive
  • Volume 77, Issue Suppl 2
  • SAT0321 Ixekizumab treatment significantly improves enthesitis and dactylitis in patients with active psoriatic arthritis: results from the spirit trials

Article info

Article menu

Download PDFPDF

Saturday, 16 JUNE 2018
Psoriatic arthritis
SAT0321 Ixekizumab treatment significantly improves enthesitis and dactylitis in patients with active psoriatic arthritis: results from the spirit trials
Free

Authors

Citation

Gladman D, Orbai A, Gallo G, et al
SAT0321 Ixekizumab treatment significantly improves enthesitis and dactylitis in patients with active psoriatic arthritis: results from the spirit trials
Annals of the Rheumatic Diseases 2018;77:1025.

Publication history

  • First published June 12, 2018.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions